Secretory Leukocyte Protease Inhibitor (SLPI) promotes hepatic resolution responses in acute liver failure (ALF)

被引：0

作者：

Triantafyllou, Evangelos ^{[1
,2
]}

Pop, Oltin T. ^{[1
]}

Liaskou, Evaggelia ^{[3
,4
]}

Bernsmeier, Christine ^{[1
]}

Khamri, Wafa ^{[2
]}

Stamataki, Zania ^{[3
,4
]}

Ma, Yun ^{[1
]}

Thursz, Mark R. ^{[2
]}

Wendon, Julia ^{[1
]}

Quaglia, Alberto ^{[1
]}

Weston, Chris J. ^{[3
,4
]}

Curbishley, Stuart M. ^{[3
,4
]}

Adams, David H. ^{[3
,4
]}

Antoniades, Charalambos G. ^{[1
,2
]}

机构：

[1] Kings Coll London, Inst Liver Studies, London WC2R 2LS, England

[2] Univ London Imperial Coll Sci Technol & Med, Sect Hepatol, London, England

[3] Univ Birmingham, NIHR Biomed Res Unit, Birmingham, W Midlands, England

[4] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

741

引用

页码：560A / 560A

页数：1

共 50 条

[1] SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) SUPPRESSES INNATE IMMUNE RESPONSES AND PROMOTES RESOLUTION OF INFLAMMATION IN AN AUTO/PARACRINE MANNER DURING ACUTE LIVER FAILURE (ALF)
Triantafyllou, E.
Liaskou, E.
Khamri, W.
Pop, O. T.
Davies, S.
Bernsmeier, C.
Stamataki, Z.
Goldin, R. D.
Ma, Y.
Quaglia, A.
Thursz, M. R.
Wendon, J.
Curbishley, S. M.
Weston, C. J.
Adams, D. H.
Antoniades, C. G.
JOURNAL OF HEPATOLOGY, 2015, 62 : S500 - S501
[2] THE ROLE OF HEPATIC SECRETORY LEUCOCYTE PROTEASE INHIBITOR (SLPI) IN A MURINE ACUTE LIVER FAILURE (ALF) MODEL
Possamai, L. A.
Petts, G.
Khamri, W.
Antoniades, C. G.
Thursz, M. R.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S118 - S118
[3] SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IS A PIVOTAL MEDIATOR OF ANTI-INFLAMMATORY RESPONSES IN ACUTE LIVER FAILURE
Antoniades, C.
Khamri, W.
Abeles, R.
O'Brien, A.
Possamai, L.
Bernal, W.
Starling, C.
Mitry, R.
Auzinger, G.
Gilroy, D.
Heneghan, M.
Heaton, N.
Quaglia, A.
Vergani, D.
Wendon, J.
Thursz, M.
JOURNAL OF HEPATOLOGY, 2013, 58 : S26 - S26
[4] SECRETORY LEUKOCYTE PROTEASE INHIBITOR DRIVES HEPATIC RESOLUTION RESPONSES IN ACUTE LIVER FAILURE THROUGH MODULATION OF THE MER TYROSINE KINASE PATHWAY
Triantafyllou, E.
Wilhelm, A.
Possamai, L.
Pop, O.
Liaskou, E.
Bernsmeier, C.
Khamri, W.
Petts, G.
Davies, S.
Abeles, R.
Stamataki, Z.
Woollard, K.
Ma, Y.
Quaglia, A.
Wendon, J.
Thursz, M.
Adams, D.
Curbishley, S.
Weston, C.
Antoniades, C.
JOURNAL OF HEPATOLOGY, 2016, 64 : S512 - S512
[5] Secretory leukocyte protease inhibitor (SLPI) regulates hepatic ischemia/reperfusion injury
Lentsch, AB
Yoshidome, H
Ward, PA
Edwards, MJ
FASEB JOURNAL, 1999, 13 (04): : A507 - A507
[6] Cloning and expression of salivary secretory leukocyte protease inhibitor (SLPI).
Tseng, CC
Tseng, CP
Lupovici, JU
Yip, J
Chou, J
JOURNAL OF DENTAL RESEARCH, 1998, 77 : 850 - 850
[7] Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer
Nugteren, Sandrine
Samsom, Janneke N.
CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 59 : 22 - 35
[8] SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IN BEHCET'S PATIENTS SALIVA
Hagi-Pavli, Eleni
Bergmeier, Lesley
Khan, Imran
Seoudi, Noha
Fortune, Farida
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S128 - S128
[9] Secretory leukocyte protease inhibitor (SLPI) as a key factor for cholangiocarcinoma progression
Phimsen, Suchada
Chueajedton, Kangsadan
Chueaiphuk, Chaiwat
Jantra, Jeranan
Sonsuwan, Anisa
Kaewkong, Worasak
Kumphune, Sarawut
Wongkham, Sopit
CANCER SCIENCE, 2025, 116 : 1092 - 1092
[10] Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa
Bergenfeldt, M
Nystrom, M
Bohe, M
Lindstrom, C
Polling, A
Ohlsson, K
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (01) : 18 - 23

← 1 2 3 4 5 →